Patent ID: 6624188
Filing Date: 2003-09-23
Classification: A61P,C07D

Abstract:
A process for administering to a female mammal, who is in the child bearing age or pregnant, a substantially non-teratogenic pharmaceutical composition containing an effective dose of a compound of the formula where the symbols are defined as follows:X4 is O, Y2 is furyl, R1, R3 and R20 are methyl, R2, R5 and R6 are hydrogen; A is (CH2)n where n is 0; and B is COOH or COOC2H5, said composition being administered to treat or prevent one or more of the diseases and conditions selected from the group consisting of dermatoses, atherosclerosis and restenosis resulting from neointimal hyperproliferation, non-malignant hyperproliferative diseases, chronic inflammatory diseases, diseases associated with lipid metabolism and transport, dry eye syndrome, for promoting wound healing, and for reversing and preventing the effects of sun damage to skin.